The landscape of T-cell engagers for the treatment of follicular lymphoma
Follicular lymphoma (FL), the second most common subtype of non-Hodgkin lymphoma, relies on interactions with immune elements in the tumor microenvironment, including T-follicular helper cells and follicular dendritic cells, for its survival and progression. Despite its initial responsiveness to che...
Saved in:
Main Authors: | Alfredo Rivas-Delgado, Ivan Landego, Lorenzo Falchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2412869 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma
by: Giulio Cassanello, et al.
Published: (2024-12-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
A phase 2 study of frontline pembrolizumab in follicular lymphoma
by: Carrie Ho, et al.
Published: (2024-12-01) -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01) -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
by: Alessia Castellino, et al.
Published: (2017-01-01)